Search

Your search keyword '"Devy Zisman"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Devy Zisman" Remove constraint Author: "Devy Zisman" Topic medicine Remove constraint Topic: medicine
76 results on '"Devy Zisman"'

Search Results

1. COVID-19 Vaccine Effectiveness among Patients with Psoriatic Disease: A Population-Based Study

2. The Risk of Herpes Zoster Events in Patients with Spondyloarthritis and the Effect of BNT162b2 mRNA COVID-19 Vaccine

3. Implementation of Calcium and Vitamin D Supplementation in Glucocorticosteroid-Induced Osteoporosis Prevention Guidelines—Insights from Rheumatologists

4. Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study

5. Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab

6. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination

7. Comorbidities in Patients with Psoriatic Arthritis

8. The Association of Psoriatic Arthritis With All-cause Mortality and Leading Causes of Death in Psoriatic Arthritis

9. High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis

10. Treatment persistence of biologics among patients with psoriatic arthritis

11. Severe biventricular thrombosis in eosinophilic granulomatosis with polyangiitis: a case report

12. <scp>US</scp> Adult Rheumatologists’ Perspectives on the Transition Process for Young Adults With Rheumatic Conditions

13. Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147

14. Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients

15. Comment on: Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series

16. Spinal Stenosis Caused by Calcinosis in a Patient With Systemic Sclerosis

17. Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice

18. Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study

19. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination

20. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

21. Implementation of recommendations for prevention of glucocorticosteroid-induced osteoporosis in hospitalized patients

22. Lupus myocarditis in an octogenarian patient—a case report

23. The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis

24. Erosive Costovertebral Joint Arthritis-An Uncommon Manifestation of Ankylosing Spondylitis

25. Polymyalgia Rheumatica: a Common Disease in Seniors

26. Increased Prevalence of Systemic Lupus Erythematosus Comorbidity in Patients With Psoriatic Arthritis: A Population-based Case-control Study

27. Increased Prevalence of Metabolic Syndrome and Adipocytokine Levels in a Psoriatic Arthritis Cohort

28. Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting

29. Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study

30. AB0551 TREATMENT WITH IXEKIZUMAB FOLLOWING SECUKINUMAB FAILURE IN PATIENTS WITH PSORIATIC ARTHRITIS: REAL-LIFE EXPERIENCE FROM A RESISTANT POPULATION

31. Comment on: Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series: reply

32. Adiposity in Juvenile Psoriatic Arthritis

33. Endocrine Comorbidities in Patients with Psoriatic Arthritis: A Population-based Case-controlled Study

34. Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis

35. AB0787 TREATMENT TRENDS IN PSORIATIC ARTHRITIS IN A REAL-WORLD SETTING; RESULTS FROM A HEALTH PROVIDER DATABASE OF THE PSORIATIC ARTHRITIS PATIENTS

36. AB0788 LUPUS CO-MORBIDITY IN PATIENTS WITH PSORIATIC ARTHRITIS: A POPULATION-BASED CASE-CONTROLLED STUDY

37. Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab

38. POS0147 ANALYSIS OF VENOUS THROMBOEMBOLIC RISK AMONG PSORIATIC ARTHRITIS PATIENTS

39. POS0613 TOCILIZUMAB DECREASES ANGIOGENESIS IN RHEUMATOID ARTHRITIS THROUGH ITS REGULATORY EFFECT ON EMMPRIN/CD147

40. POS1217 THE PATTERN OF COVID 19 PANDEMIC AMONG PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES (AIIRD)

41. POS0974 IMPROVEMENT IN THE DIAGNOSTIC DELAY OF AXIAL SPONDYLOARTHRITIS, RESULTS FROM REAL WORLD DATA

42. FRI0337 REAL WORLD SECUKINUMAB DRUG-SURVIVAL IN PSORIATIC ARTHRITIS

43. AB0780 TREATMENT PERSISTENCE OF BIOLOGICS AMONG PATIENTS WITH PSORIATIC ARTHRITIS (PsA)

44. The Effect of Pregnancy on Disease Activity in Patients with Psoriatic Arthritis

45. THU0197 Effects of tocilizumab, an anti-interleukin-6 receptor antibody, on serum lipid and adipokine levels in patients with rheumatoid arthritis

46. THU0288 Implementation of the treat to target concept in evaluation of psoriatic arthritis patients

47. The epidemiology of psoriatic arthritis in Israel – a population-based study

48. Systemic lupus erythematosus exacerbation following cessation of belimumab treatment

49. Psoriatic arthritis treatment and the risk of herpes zoster

50. The fetal outcomes of pregnancies of systemic lupus erythematosus patients in northern Israel

Catalog

Books, media, physical & digital resources